Akihiro Ohira Selected Research

Akihiro Ohira Research Topics

Disease

7	Glaucoma 01/2017 - 02/2004
7	Cataract (Cataracts) 08/2014 - 02/2002
6	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2017 - 02/2002
5	Macular Degeneration (Age-Related Maculopathy) 05/2018 - 01/2008
3	Exfoliation Syndrome 12/2020 - 01/2012
3	Retinal Degeneration 03/2019 - 09/2011
2	Gliosis 01/2019 - 01/2016
2	Uveitis 01/2012 - 07/2009
1	Anterior Uveitis 12/2020
1	Corneal Ulcer 12/2020
1	Body Weight (Weight, Body) 05/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016
1	Stroke (Strokes) 05/2013
1	Retinal Artery Occlusion 04/2013
1	Myopia 09/2012
1	Epiretinal Membrane (Epiretinal Membranes) 05/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Asthenopia (Eyestrain) 01/2012
1	Macular Edema 10/2011
1	Gyrate Atrophy 09/2011
1	Retinal Detachment (Retinal Detachments) 01/2009
1	Amyloidosis 01/2009
1	Photosensitivity Disorders (Photodermatitis) 05/2008
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2008
1	Polypoidal Choroidal Vasculopathy 01/2008
1	Choroidal Neovascularization 01/2008
1	Cicatrix (Scar) 01/2008
1	Neoplasms (Cancer) 07/2004
1	Corneal Injuries 07/2003
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2003
1	Cerebral Infarction 03/2002
1	Hyphema 02/2002
1	Myopia 10 02/2002

Drug/Important Bio-Agent (IBA)

12	Retinaldehyde (Retinal)IBA 01/2019 - 03/2002
4	AntioxidantsIBA 05/2018 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 03/2019 - 05/2008
2	Antiglaucoma AgentsIBA 01/2017 - 02/2002
2	LuteinIBA 09/2012 - 01/2008
2	ZeaxanthinsIBA 09/2012 - 01/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 03/2019
1	QuercetinIBA 03/2019
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 03/2019
1	LipidsIBA 10/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Ranibizumab (Lucentis)FDA Link 01/2017
1	Sulfur HexafluorideIBA 01/2016
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2015
1	Alprostadil (Muse)FDA LinkGeneric 04/2013
1	Interleukin-8 (Interleukin 8)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	CytokinesIBA 01/2012
1	tetramethylpyrazineIBA 01/2012
1	baicalinIBA 01/2012
1	keishibukuryoganIBA 01/2012
1	oren gedoku toIBA 01/2012
1	sairei-toIBA 01/2012
1	wogoninIBA 01/2012
1	kakkon-toIBA 01/2012
1	xygan-ming-mu-tangIBA 01/2012
1	trans-sodium crocetinate (crocetin)IBA 01/2012
1	BerberineIBA 01/2012
1	baicaleinIBA 01/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2011
1	CyclodextrinsIBA 10/2011
1	Ophthalmic Solutions (Eye Drops)IBA 10/2011
1	Macular PigmentIBA 09/2011
1	OrnithineIBA 09/2011
1	Retinal Pigments (Pigments, Visual)IBA 05/2008
1	Free RadicalsIBA 05/2008
1	4-hydroxyhexenalIBA 05/2008
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 05/2008
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2008
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2008
1	Carotenoids (Carotene)IBA 01/2008
1	ConnexinsIBA 11/2005
1	von Willebrand FactorIBA 07/2004
1	Carteolol (Carteolol Hydrochloride)FDA LinkGeneric 07/2003
1	Hydroxyl RadicalIBA 07/2003
1	rebamipideIBA 07/2003

Therapy/Procedure

3	Intraocular Lens Implantation 08/2014 - 02/2002
3	Intraocular Lenses (Intraocular Lens) 09/2011 - 10/2002
3	Trabeculectomy (Trabeculoplasty) 01/2009 - 02/2002
2	Vitrectomy 01/2016 - 05/2012
2	Phacoemulsification 10/2002 - 02/2002
1	Oral Administration 05/2018
1	Catheters 01/2016
1	Filtering Surgery 01/2015
1	Solid-State Lasers 01/2015
1	Intravenous Injections 01/2012
1	Decompression 01/2009
1	Lasers (Laser) 04/2003